These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. MK-801 subsensitivity following postweaning lead exposure. Cory-Slechta DA Neurotoxicology; 1995; 16(1):83-95. PubMed ID: 7603648 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat. Shannon HE J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266 [TBL] [Abstract][Full Text] [Related]
25. Effect of dizocilpine maleate on discriminative properties of methamphetamine in rats. Liang JC; Zheng IW Acta Pharmacol Sin; 2000 Jul; 21(7):605-8. PubMed ID: 11360666 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. Shannon HE J Pharmacol Exp Ther; 1982 Jul; 222(1):146-51. PubMed ID: 7086696 [TBL] [Abstract][Full Text] [Related]
27. Discriminative stimulus properties of dextromethorphan in rats. Gavend M; Mallaret M; Dematteis M; Baragatti G Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072 [TBL] [Abstract][Full Text] [Related]
28. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. Koek W; Woods JH; Colpaert FC J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142 [TBL] [Abstract][Full Text] [Related]
30. Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties. Jacobson AE; Harrison EA; Mattson MV; Rafferty MF; Rice KC; Woods JH; Winger G; Solomon RE; Lessor RA; Silverton JV J Pharmacol Exp Ther; 1987 Oct; 243(1):110-7. PubMed ID: 2822892 [TBL] [Abstract][Full Text] [Related]
31. Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys. Brady KT; Woolverton WL; Balster RL J Pharmacol Exp Ther; 1982 Jan; 220(1):56-62. PubMed ID: 6118431 [No Abstract] [Full Text] [Related]
32. Effect of chronic MK-801 and/or phenytoin on the acquisition of complex behaviors in rats. Wright LK; Popke EJ; Allen RR; Pearson EC; Hammond TG; Paule MG Neurotoxicol Teratol; 2007; 29(4):476-91. PubMed ID: 17376648 [TBL] [Abstract][Full Text] [Related]
33. Separation of the response rate and discriminative stimulus effects of phencyclidine: training dose as a factor in phencyclidine-saline discrimination. Beardsley PM; Balster RL; Salay JM J Pharmacol Exp Ther; 1987 Apr; 241(1):159-65. PubMed ID: 3572780 [TBL] [Abstract][Full Text] [Related]
34. Phencyclidine-like discriminative effects of opioids in the rat. Holtzman SG J Pharmacol Exp Ther; 1980 Sep; 214(3):614-9. PubMed ID: 6105206 [TBL] [Abstract][Full Text] [Related]
35. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys. Katz JL; Spealman RD; Clark RD J Pharmacol Exp Ther; 1985 Feb; 232(2):452-61. PubMed ID: 3968644 [TBL] [Abstract][Full Text] [Related]
36. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. Bobelis DJ; Balster RL J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128 [TBL] [Abstract][Full Text] [Related]
38. Discriminative stimulus effects of nalbuphine in rhesus monkeys. Gerak LR; France CP J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318 [TBL] [Abstract][Full Text] [Related]
39. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261 [TBL] [Abstract][Full Text] [Related]